drugset / Trial / NCT03420937

Deep Neuromuscular Block During General Anaesthesia in Robotic Surgery

NCT03420937

RandomizedParallel-groupSingle-blindTreatment

Summary

The aim of this project is to show, whether the use of the deep neuromuscular block in certain laparoscopic robot-assisted surgery can positively influence main physiological functions compared to the use of standard neuromuscular block. Secondary outcome is to find out whether the targeted specific reversal of neuromuscular block by sugammadex improves and fastens the post-operative recovery of the patients.

Timeline

Start
2016-06
Primary completion
2017-06
Completion
2017-08

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Neostigmine Other / unclassified 0.03 mg/kg Intravenous
Subject Sugammadex Other / unclassified 2 mg/kg Intravenous
Subject Sugammadex Other / unclassified 4 mg/kg Intravenous
Background Atropin Biotika Unknown 0.5 mg Intravenous
Background Atropin Biotika Unknown 1 mg Intravenous

Indications

No indication recorded.